ORBITAL ITN The ORBITAL (Ocular Research By Integrated Training And Learning) network is an EU-funded Marie Sklodowska-Curie Innovation Training Network (MSCA-ITN, GA 813440).This ITN will recruit and train 15 early stage researchers (PhD students) across Europe to develop drug delivery technologies that can help treat posterior segment diseases of the eye, e.g. age-related macular degeneration and diabetic retinopathy. In so doing, ORBITAL aims to improve the quality of life and clinical outcomes for patients with these conditions. The network is built on an intersectoral consortium (academia, industry, clinicians, patient advocacy groups and hospitals) composed of 23 members from Europe, Canada and the US. The goal is to train researchers to PhD level, ensuring that they have a clear focus on patient needs and interdisciplinary skills. We will have a strong focus on outreach, dissemination, patient and public engagement. ORBITAL ITN’s tracks Developing drug delivery strategies for ocular therapeutics by ORBITAL ITN published on 2022-05-09T15:29:35Z ORBITAL and 9Plus talk Ocular Therapeutics, w/ Larry Fitzhenry, Niall O'Reilly, and Tess Ames by ORBITAL ITN published on 2022-04-07T11:20:58Z Beyond Science Part 5 - A Look Toward The Top by ORBITAL ITN published on 2021-05-26T13:55:31Z Beyond Science Part 4 - Biomedical Future by ORBITAL ITN published on 2021-05-06T09:07:33Z Beyond Science Part 3 - Final Stretch Mentality by ORBITAL ITN published on 2021-03-25T15:27:57Z Beyond Science Part 2, "Doctor, what now?" by ORBITAL ITN published on 2021-03-02T15:20:10Z Beyond Science: Part 1 - PhD, a conscious choice by ORBITAL ITN published on 2021-02-09T14:12:34Z An Interview with David Kent, Consultant Ophthalmic Surgeon & Retinal Specialist by ORBITAL ITN published on 2020-07-02T14:23:20Z The Future Of Additive Manufacturing For The Biomedical Sector Dr Sean Lyons by ORBITAL ITN published on 2020-03-09T10:27:30Z Understanding the role of Gender in EU-Funded Research and Innovation Programmes by ORBITAL ITN published on 2020-02-24T09:17:22Z
Developing drug delivery strategies for ocular therapeutics by ORBITAL ITN published on 2022-05-09T15:29:35Z
ORBITAL and 9Plus talk Ocular Therapeutics, w/ Larry Fitzhenry, Niall O'Reilly, and Tess Ames by ORBITAL ITN published on 2022-04-07T11:20:58Z
An Interview with David Kent, Consultant Ophthalmic Surgeon & Retinal Specialist by ORBITAL ITN published on 2020-07-02T14:23:20Z
The Future Of Additive Manufacturing For The Biomedical Sector Dr Sean Lyons by ORBITAL ITN published on 2020-03-09T10:27:30Z
Understanding the role of Gender in EU-Funded Research and Innovation Programmes by ORBITAL ITN published on 2020-02-24T09:17:22Z
